Navigation Links
X-Change Corporation Signs Multi-Million Dollar Agreement for Multi-State Product Release Licensing, Medical Cannabis Dispensary Management, and Cultivation Consulting
Date:8/20/2013

COLORADO SPRINGS, Colo., Aug. 20, 2013 /PRNewswire/ -- The X-Change Corporation (NASDAQ OTC: XCHC), a U.S. Company specializing in cannabinoid formulation-based health and wellness solutions, entered into a multi-year, strategic growth agreement with Medicine Dispensing Systems, a wholly owned subsidiary of Medbox, Inc., a publicly traded company, to provide its scientific and clinical expertise for ten medical cannabis dispensaries and cultivation facilities in the states of Arizona, California, Illinois, Massachusetts, Nevada, and Washington State. 

This milestone agreement provides X-Change Corp with the real opportunity to develop premiere branding and to introduce the Company's proprietary cannabinoid-based products and formulations within each state's regulatory framework.

Dr. Dorothy Bray, President of X-Change Corporation, stated, "This agreement will allow X-Change Corp to introduce much needed scientific research and improved clinical management into dispensaries to benefit patients. Medbox represents the gold standard in pharmaceutical and alternative medication dispensing and will help us to employ best-in-industry practices and improve our focus on clinical management aspects, accompanied by the scientific documentation and research to monitor clinical progress of patients.  Our novel approach position will set us even further apart from our competitors."

Under the agreement, as a part of each dispensary build-out, X-Change Corp will brand the operations with a new image and employ a market-exclusive use of the patented Medbox system. Medbox technology and software allows for biometric patient and employee identification, internal documentation and tracking of dispensing services for internal accounting and compliance purposes, and secure inventory management and control.  In its efforts to enter the legal medical cannabis dispensary space, X-Change Corp expects to announce the signing of a significant dispensary management agreement in the very near term.

About The X-Change Corporation


The X-Change Corporation is currently developing new natural cannabinoid containing products based on innovative formulations to utilize the unique and potent benefits of the cannabis and hemp plants. Medicinal properties of cannabis and hemp have been known and applied for thousands of years. With the aid of scientific research, The X-Change Corporation is translating such knowledge into development of effective cannabinoid formulation-based health and wellness solutions as well as cosmeceutical, nutraceutical, and food brands throughout the world. The Company's health and wellness, nutritional, and cosmetics lines will address personal needs and will evolve with the introduction of new formulations and products, advancing the Company within the expanding multibillion-dollar global market.

Forward Looking Statements


This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. X-Change Corp. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

X-Change Corp. 
President

Dr. Dorothy Bray
info@xchangecorp.com
www.xchangecorp.com
+1.866.326.5595

Investment Inquiries

Robert Kane

CFO, Sr Vp of Business Development
rkane@xchangecorp.com
+1.561.420.4824

 


'/>"/>
SOURCE The X-Change Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Medbox Signs Multi-State Consulting Deal with X-Change Corporation
2. X-Change Corporation Launches Upgraded Version of Phytiva Website, As Company Targets Distribution of Phytiva Product Line in United States and Worldwide, Extracts and New Products in Europe
3. Ambit Biosciences Corporation Announces Second Quarter 2013 Operational Results
4. Dynasil Corporation of America Reports Third Quarter Fiscal 2013 Financial Results
5. Omeros Corporation Reports Second Quarter 2013 Financial Results
6. Celsion Corporation Reports Second Quarter 2013 Financial Results and Provides HEAT Study Update
7. Techne Corporation Releases Unaudited Fourth Quarter And Fiscal Year 2013 Results
8. DURECT Corporation Announces Second Quarter 2013 Financial Results and Update of Programs
9. Psychemedics Corporation Announces Top Revenue Quarter
10. Celsion Corporation to Hold Second Quarter 2013 Financial Results Conference Call on Thursday, August 8, 2013
11. Comprehensive Care Corporation Signs Agreement With A National Leader In Pharmacy Benefit Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , Tenn. and DALLAS , April 19, ... Inc., announced that the first patients in ... EndoStim device in the Lower Esophageal Sphincter Stimulation for ... minimally-invasive implantable device designed to provide long-term reflux control ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-na├»ve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... 18, 2017 Research and Markets has announced ... report to their offering. ... global arthroscopy devices market to grow at a CAGR of 6.35% ... Devices Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce ... process has been in place since the RBMA was founded in 1968 with all ... Jim Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson the chief executive officer for ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... and College of Urgent Care Medicine will host industry leaders for the annual ... will help those in the industry adapt to the issues currently affecting urgent ...
(Date:4/28/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has ... which He does not. Yisrayl says with so many titles and names for the ... he says with a little Scripture, backed with a lot of research, the truth is ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... skincare and advanced nutraceutical supplements, through its Nova Skin Sciences division, recently ... hydrating benefits of a moisturizer with the power of an anti-aging concentrate. ...
(Date:4/28/2017)... ... 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Medical Inc. , a leader in infusion therapy and pain management. , Intravenous ... percent of hospital patients receiving a peripheral IV catheter as part of their treatment ...
Breaking Medicine News(10 mins):